November 20th, 2015 | by
Great Britain Association Insulin glargine is a long acting analogue insulin Lantus is an analogue insulin produced by Sanofi-Aventis with the medical name insulin glargine. Lantus has been available for pharmaceutical use since the year 2000. Lantus hit
November 20th, 2015 | by
Great Britain Association Insulin degludec is an ultra long acting basal insulin Insulin degludec, which is supplied under trade name Tresiba, is an ultra long acting basal insulin which can be used by people with type 1 or type 2 diabetes. Tresiba last
October 1st, 2015 | by
American Association Muscle Whole-body insulin resistance is the earliest predictor of type 2 diabetes onset, and this mainly reflects muscle insulin resistance. However, careful separation of the contributions of muscle and liver have shown that
Insulin resistance occurs when insulin levels are sufficiently high over a prolonged period of time causing the body’s own sensitivity to the hormone to be reduced. Once the body starts to get resistant to insulin, it can be a
